170 related articles for article (PubMed ID: 22761949)
1. Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.
Rütgen BC; Willenbrock S; Reimann-Berg N; Walter I; Fuchs-Baumgartinger A; Wagner S; Kovacic B; Essler SE; Schwendenwein I; Nolte I; Saalmüller A; Murua Escobar H
PLoS One; 2012; 7(6):e40078. PubMed ID: 22761949
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
Rütgen BC; Hammer SE; Gerner W; Christian M; de Arespacochaga AG; Willmann M; Kleiter M; Schwendenwein I; Saalmüller A
Leuk Res; 2010 Jul; 34(7):932-8. PubMed ID: 20153049
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Stem Cell Marker Expression in Canine B-Cell Lymphoma Cell Lines, B-Cell Lymphoma-generated Spheres and Primary Samples.
Liu W; Selçuk F; Rütgen BC; Moulay M; Willenbrock S; Hammer SE; Sterenczak KA; Junghanss C; Hewicker-Trautwein M; Nolte I; Murua Escobar H
Anticancer Res; 2015 May; 35(5):2805-16. PubMed ID: 25964560
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the death-associated protein kinase CpG island in canine B-cell lymphoid tumors.
Sato M; Mochizuki H; Goto-Koshino Y; Fujiwara-Igarashi A; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):222-31. PubMed ID: 25193469
[TBL] [Abstract][Full Text] [Related]
5. Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.
Taher L; Beck J; Liu W; Roolf C; Soller JT; Rütgen BC; Hammer SE; Chodisetti M; Sender S; Sterenczak KA; Fuellen G; Junghanss C; Brenig B; Nolte I; Schütz E; Murua Escobar H
Sci Rep; 2018 Apr; 8(1):6279. PubMed ID: 29674676
[TBL] [Abstract][Full Text] [Related]
6. Application of Immunophenotyping and Heteroduplex Polymerase Chain Reaction (hPARR) for Diagnosis of Canine Lymphomas.
Sirivisoot S; Techangamsuwan S; Tangkawattana S; Rungsipipat A
Asian Pac J Cancer Prev; 2016; 17(6):2909-16. PubMed ID: 27356711
[TBL] [Abstract][Full Text] [Related]
7. A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.
Ito D; Endicott MM; Jubala CM; Helm KM; Burnett RC; Husbands BD; Borgatti A; Henson MS; Burgess KE; Bell JS; Kisseberth WC; Valli VE; Cutter GR; Avery AC; Hahn KA; O'Brien TD; Modiano JF
J Vet Intern Med; 2011; 25(4):890-6. PubMed ID: 21777289
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological targeting of valosin containing protein (VCP) induces DNA damage and selectively kills canine lymphoma cells.
Nadeau MÈ; Rico C; Tsoi M; Vivancos M; Filimon S; Paquet M; Boerboom D
BMC Cancer; 2015 Jun; 15():479. PubMed ID: 26104798
[TBL] [Abstract][Full Text] [Related]
9. Cancer-specific apoptosis induction in canine lymphoma cell lines by the endocytosis inhibitor dynasore.
Suemura M; Miyata H; Kawamura R; Takahashi S; Igase M; Mizuno T; Ohama T; Shibutani S; Iwata H
J Vet Med Sci; 2023 Aug; 85(8):820-827. PubMed ID: 37407446
[TBL] [Abstract][Full Text] [Related]
10. Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma.
André AS; Dias JNR; Aguiar SI; Leonardo A; Nogueira S; Amaral JD; Fernandes C; Gano L; Correia JDG; Cavaco M; Neves V; Correia J; Castanho M; Rodrigues CMP; Gaspar MM; Tavares L; Aires-da-Silva F
Front Vet Sci; 2023; 10():1236136. PubMed ID: 37711439
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
Dias JNR; André AS; Aguiar SI; Ministro J; Oliveira J; Peleteiro MC; Rütgen B; Gano L; Correia JDG; Oliveira SS; Goncalves J; Gil S; Tavares L; Aires-da-Silva F
PLoS One; 2018; 13(12):e0208147. PubMed ID: 30592723
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
Roode SC; Rotroff D; Richards KL; Moore P; Motsinger-Reif A; Okamura Y; Mizuno T; Tsujimoto H; Suter SE; Breen M
BMC Vet Res; 2016 Sep; 12():207. PubMed ID: 27639374
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol Strongly Sensitizes Canine Lymphoma Cells to TRAIL-induced Apoptosis.
Pawlak A; DE Miguel D; Kutkowska J; Obmińska-Mrukowicz B; Rapak A; Martinez-Lostao L
Anticancer Res; 2017 Dec; 37(12):6655-6665. PubMed ID: 29187441
[TBL] [Abstract][Full Text] [Related]
14. BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.
Kong W; Sender S; Taher L; Villa-Perez S; Ma Y; Sekora A; Ruetgen BC; Brenig B; Beck J; Schuetz E; Junghanss C; Nolte I; Murua Escobar H
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884478
[TBL] [Abstract][Full Text] [Related]
15. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
16. Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma.
Omer S; Pathak S; Nadar R; Bowen D; Sandey M; Dhanasekaran M; Pondugula S; Mansour M; Boothe D
Life Sci; 2023 Aug; 327():121862. PubMed ID: 37330042
[TBL] [Abstract][Full Text] [Related]
17. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
18. A retrospective histopathological survey on canine lymphomas subtypes of Porto District.
Pinello K; Santos M; Dias-Pereira P; Niza-Ribeiro J; de-Matos A
Open Vet J; 2023 Apr; 13(4):443-450. PubMed ID: 37251261
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line.
Hsu CH; Tomiyasu H; Liao CH; Lin CS
PLoS One; 2021; 16(5):e0250013. PubMed ID: 33961622
[TBL] [Abstract][Full Text] [Related]
20. Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment.
Mizuno T; Kato Y; Kaneko MK; Sakai Y; Shiga T; Kato M; Tsukui T; Takemoto H; Tokimasa A; Baba K; Nemoto Y; Sakai O; Igase M
Sci Rep; 2020 Jul; 10(1):11476. PubMed ID: 32651429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
